Page last updated: 2024-11-06

thyroxine and Follicular Thyroid Carcinoma

thyroxine has been researched along with Follicular Thyroid Carcinoma in 89 studies

Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.

Research Excerpts

ExcerptRelevanceReference
"We experienced two cases of follicular thyroid carcinoma with distant metastases, which showed high levels of free triiodothyronine (T(3)) while free thyroxine (T(4)) levels remained in the low or normal range."7.73Thyroxine to triiodothyronine hyperconversion thyrotoxicosis in patients with large metastases of follicular thyroid carcinoma. ( Amino, N; Ito, Y; Miyauchi, A; Takano, T, 2006)
"The aim was to analyze the impact of combined treatment (thyroidectomy + radioactive iodine treatment + hormonotherapy with thyroxine) on the outcomes of patients with follicular thyroid carcinoma."3.76[Outcomes of long-term combined treatment in follicular thyroid carcinoma]. ( Baranauskas, Z; Tiskevicius, S; Valuckas, KP, 2010)
" The skull and brain tumors had been successfully treated by surgery, thyroxine supplementation, and radiosurgery until she died of sudden intracerebral hemorrhage which had no connection with tumor treatment."3.73Thyroid follicular carcinoma metastasized to the lung, skull, and brain 12 years after initial treatment for thyroid gland--case report. ( Ogawa, Y; Sakuma, T; Seki, H; Sugawara, T, 2006)
"We experienced two cases of follicular thyroid carcinoma with distant metastases, which showed high levels of free triiodothyronine (T(3)) while free thyroxine (T(4)) levels remained in the low or normal range."3.73Thyroxine to triiodothyronine hyperconversion thyrotoxicosis in patients with large metastases of follicular thyroid carcinoma. ( Amino, N; Ito, Y; Miyauchi, A; Takano, T, 2006)
" In papillary carcinoma thyroxine administration (P < 0."3.69Thyroid cancer: a multivariate analysis on influence of treatment on long-term survival. ( Staunton, MD, 1994)
"These negative findings, that thyroxine in suppressive doses does not significantly reduce bone mineral density in New Zealand patients suggest that thyroxine therapy alone is not a major risk factor for the development of osteoporosis."3.68Bone mineral density in patients receiving suppressive doses of thyroxine for thyroid carcinoma. ( Ayling, EM; Brownlie, BE; Elliot, JR; Florkowski, CM; Turner, JG, 1993)
" Multivariate regression modelling was applied to assess the association of T4 dosing with polymorphisms in UGT1A1 (rs8175347), UGT1A3 (rs3806596 and rs1983023), DIO1 (rs11206244 and rs2235544) and DIO2 (rs225014 and rs12885300), demographic and clinical variables."2.79Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer. ( Barros Filho, Mde C; Bulzico, DA; Kowalski, LP; Meirelles, RM; Neves, RR; Paula, DP; Pessoa, CN; Santoro, AB; Struchine, CJ; Suarez-Kurtz, G; Vargens, DD, 2014)
"Distant metastases from thyroid cancer of follicular origin are uncommon."2.58Treatment of refractory thyroid cancer. ( Berdelou, A; Klain, M; Lamartina, L; Leboulleux, S; Schlumberger, M, 2018)
"Differentiated thyroid cancer (DTC) is a rare malignant disease, although its incidence has increased over the last few decades."2.55Differentiated Thyroid Cancer-Treatment: State of the Art. ( Grosse, J; Hellwig, D; Menhart, K; Schmidbauer, B, 2017)
"The management of nodules and thyroid cancer is evolving."2.53Advances in the management of differentiated thyroid cancer with follicular cell strain. ( Ben Ali, M; Ben Raies, N; Ben Slimène, F; Karboua, E; Mhiri, A; Schlumberger, M; Slimène, H, 2016)
"Thyroid cancer is the most common endocrine malignancy, although representing fewer than 1% of all human tumors."2.48Approach to and treatment of differentiated thyroid carcinoma. ( Castagna, MG; Pacini, F, 2012)
"We retrospectively reviewed 234 follicular thyroid carcinoma cases to compare the diagnostic and therapeutic characteristics between the minimally and the widely invasive types."2.47Diagnostic and therapeutic strategies for minimally and widely invasive follicular thyroid carcinomas. ( Chao, TC; Hsueh, C; Huang, CC; Lin, JD; Liu, FH, 2011)
"Papillary and follicular thyroid carcinomas are among the most curable of all cancers."2.41Papillary and follicular thyroid carcinoma. ( Schlumberger, MJ; Torlantano, M, 2000)
"In differentiated thyroid cancer (DTC), the standard treatment includes total thyroidectomy and lifetime levothyroxine (LT4) replacement."1.62Effects of Chronic Suppression or Oversuppression of Thyroid-Stimulating Hormone on Psychological Symptoms and Sleep Quality in Patients with Differentiated Thyroid Cancer. ( Altuntaş, SÇ; Hocaoğlu, Ç, 2021)
"Thyroid cancer is on the rise."1.43SAHA-induced loss of tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse model. ( Cheng, SY; Kim, DW; Willingham, MC; Zhao, L; Zhu, X, 2016)
"In patients with differentiated thyroid cancer (DTC), the stimulated serum thyroglobulin (Tg) level at radioiodine ablation is a known predictive factor of persistent disease."1.40Stimulated thyroglobulin level at ablation in differentiated thyroid cancer: the impact of treatment preparation modalities and tumor burden. ( Bardet, S; Blanchard, D; Ciappuccini, R; de Raucourt, D; Hardouin, J; Heutte, N; Quak, E; Rame, JP; Vaur, D, 2014)
"Hypothyroidism is a common endocrine disorder frequently accompanied by alterations in lipid metabolism, such as hypercholesterolemia and high circulating triglycerides, both risk factors for nonischemic cardiomyopathy."1.40Levothyroxine replacement in hypothyroid humans reduces myocardial lipid load and improves cardiac function. ( Baumgartner-Parzer, S; Duan, H; Einwallner, E; Gessl, A; Hoffmann, M; Krebs, M; Krššák, M; Luger, A; Niessner, A; Scherer, T; Trattnig, S; Winhofer, Y; Wolf, P, 2014)
"While papillary and follicular thyroid cancer usually has an excellent prognosis, recurrent and aggressive forms of the disease do occur."1.36[Follow-up of papillary and follicular thyroid cancer--when and where?]. ( Mäenpää, HO; Välimäki, MJ, 2010)
"Tetraiodothyroacetic acid (tetrac) is a deaminated analogue of L-thyroxine that blocks the actions of L-thyroxine and 3,5,3'-triiodo-L-thyronine at the cell surface receptor for thyroid hormone on integrin alpha v beta 3."1.36Tetraiodothyroacetic acid and tetraiodothyroacetic acid nanoparticle effectively inhibit the growth of human follicular thyroid cell carcinoma. ( Bharali, DJ; Davis, FB; Davis, PJ; Dier, E; Dyskin, E; Lansing, L; Mousa, SA; Mousa, SS; Yalcin, M, 2010)
"Trifluralin treatment increased bile flow, caused a 3."1.35Mechanism of trifluralin-induced thyroid tumors in rats. ( Bartels, MJ; Brzak, KA; Charles, GD; Clark, AJ; Dryzga, MD; Kan, LH; Saghir, SA, 2008)
"In conclusion, these data indicate that thyroid neoplasms observed in the nelfinavir-treated rats were secondary to thyroid hormone imbalance."1.33Increase in thyroid follicular cell tumors in nelfinavir-treated rats observed in a 2-year carcinogenicity study is consistent with a rat-specific mechanism of thyroid neoplasia. ( Burns-Naas, LA; Capen, CC; Chen, M; Cook, JC; Evering, W; Furman, G; Gasser, R; Ivett, JL; Jessen, B; McClain, RM; Ryan, TE; Shetty, B; Stevens, G; Theiss, JC; Webber, S; Wu, E; Zorbas, M, 2005)
"Eleven children with differentiated thyroid cancer were included."1.33Children with differentiated thyroid cancer achieve adequate hyperthyrotropinemia within 14 days of levothyroxine withdrawal. ( Huang, SA; Kuijt, WJ, 2005)
"Detection of thyroid cancer by thyroglobulin (Tg) assay in peripheral blood is useful in the absence of residual thyroid tissue, but it requires thyrotropin stimulation for maximal sensitivity and is affected by circulating antithyroglobulin antibodies."1.32Evaluation of quantitative measurement of thyroglobulin mRNA in the follow-up of differentiated thyroid cancer. ( Delfino, C; Denizot, A; Dutour-Meyer, A; Fina, F; Ouafik, L, 2003)
"We report a case of follicular thyroid carcinoma discovered after surgical treatment of a toxic multinodular goiter, in which solitary adrenal gland metastasis was detected five years later."1.31Solitary adrenal gland metastasis of a follicular thyroid carcinoma presenting with hyperthyroidism. ( López-Aznar, D; Ponce, JL; Prieto, M; Sancho-Fornos, S; Yunta, PJ, 2001)
"Lymph node metastases were detected in 5 of these patients by whole body scan (WBS) and removed surgically in 3."1.31Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer. ( Cavaliere, H; Knobel, M; Lima, N; Medeiros-Neto, G; Tomimori, E, 2002)
"In 13 patients with macrometastases-tumors 1 cm or greater-tumors progressed and serum Tg increased; five have died of thyroid cancer."1.31Lack of impact of radioiodine therapy in tg-positive, diagnostic whole-body scan-negative patients with follicular cell-derived thyroid cancer. ( Fatourechi, V; Gorman, CA; Hay, ID; Javedan, H; Mullan, BP; Wiseman, GA, 2002)
"In 3 patients papillary thyroid cancer was associated with chronic lymphocytic thyroiditis."1.30Thyroid carcinoma in children and adolescents. ( Andreoli, M; Danese, D; Farsetti, A; Gardini, A; Pontecorvi, A; Sciacchitano, S, 1997)
"The most probable cause of the inadequate TSH suppression in our patients was the reduction in bioavailability in certain batches of Levothroid, although we are unable to rule out the possibility that the results obtained after the changeover to Dexnon were due to its greater bioavailability."1.30Altered bioavailability due to changes in the formulation of a commercial preparation of levothyroxine in patients with differentiated thyroid carcinoma. ( Almaraz, MC; Garriga, MJ; Gonzalez-Romero, S; Olveira, G; Ruiz de Adana, MS; Soriguer, F; Tinahones, F, 1997)
"One liver metastasis could not be detected because of the physiologic tracer distribution of 99mTc-tetrofosmin."1.30Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma. ( Gallowitsch, HJ; Gomez, I; Kresnik, E; Lind, P; Mikosch, P; Unterweger, O, 1998)
"The ideal therapy for differentiated thyroid cancer is uncertain."1.30Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. ( Ain, KB; Bigos, ST; Brierley, JD; Cooper, DS; Haugen, BR; Ho, M; Klein, I; Ladenson, PW; Maxon, HR; Robbins, J; Ross, DS; Sherman, SI; Specker, B; Sperling, M; Taylor, T, 1998)
"Patients with thyroid cancer are monitored for disease recurrence by measurement of serum thyroglobulin (Tg) and iodine-131 (131I) scanning."1.30Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma. ( Anderson, JS; Balducci-Silano, PL; Burman, KD; Francis, GL; Ladenson, PW; Levine, MA; Ringel, MD; Silverman, J; Sparling, YH; Spencer, CA; Tuttle, RM; Wartofsky, L, 1999)
"In the follicular thyroid carcinoma line FTC-133, nanomolar concentrations of 9-cis, 13-cis-, and all-trans-RA induced 5'DI activity."1.29Retinoids stimulate type I iodothyronine 5'-deiodinase activity in human follicular thyroid carcinoma cell lines. ( Köhrle, J; Schmutzler, C; Schnieders, F; Schreck, R, 1994)
"In a study of 136 differentiated thyroid cancer patients referred for radioiodine therapy since January 1991, it was observed that 80 patients had metastatic disease."1.29Thyroid hormones in differentiated thyroid cancer. ( Desai, KB; Mehta, MN; Samuel, AM, 1994)
"The patient presented recurrences of metastatic skin nodules, lung and bone metastases, and died after a 3-year follow-up."1.29Cutaneous metastasis from follicular carcinoma of the thyroid gland. ( Bazex, J; Caron, P; Gorguet, B; Moreau-Cabarrot, A, 1993)
"in an advanced stage with multiple metastases in the skeletal system, lungs and hilar lymph nodes."1.29[T3 hyperthyroidism with metastatic follicular thyroid carcinoma in substitution therapy]. ( Flesch, M; Lang, M, 1996)

Research

Studies (89)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's23 (25.84)18.2507
2000's36 (40.45)29.6817
2010's28 (31.46)24.3611
2020's2 (2.25)2.80

Authors

AuthorsStudies
Altuntaş, SÇ1
Hocaoğlu, Ç1
van Veelen, NM1
Fischli, S1
Beeres, FJP1
Eisenhut, T1
Babst, R1
Henzen, C1
Link, BC1
Schmidbauer, B1
Menhart, K1
Hellwig, D1
Grosse, J1
Fussey, JM1
Khan, H1
Ahsan, F1
Prashant, R1
Pettit, L1
Berdelou, A1
Lamartina, L1
Klain, M2
Leboulleux, S2
Schlumberger, M4
Li, P1
Zhang, A1
Liu, Y1
Xu, C1
Tang, L1
Yuan, H1
Liu, Q1
Wang, X1
Feng, D1
Wang, L1
Huang, G1
Song, S1
Mousavi, Z1
Dourandish, L1
Rokni, H1
Sadeghi, R1
Rasoul Zakavi, S1
Ciappuccini, R1
Hardouin, J1
Heutte, N1
Vaur, D1
Quak, E1
Rame, JP1
Blanchard, D1
de Raucourt, D1
Bardet, S1
Santoro, AB1
Vargens, DD1
Barros Filho, Mde C1
Bulzico, DA1
Kowalski, LP1
Meirelles, RM1
Paula, DP1
Neves, RR1
Pessoa, CN1
Struchine, CJ1
Suarez-Kurtz, G1
Scherer, T1
Wolf, P1
Winhofer, Y1
Duan, H1
Einwallner, E1
Gessl, A1
Luger, A1
Trattnig, S1
Hoffmann, M1
Niessner, A1
Baumgartner-Parzer, S1
Krššák, M1
Krebs, M1
Handkiewicz-Junak, D1
Gawlik, T1
Rozkosz, J1
Puch, Z1
Michalik, B1
Gubala, E1
Krajewska, J1
Kluczewska, A1
Jarzab, B1
Shen, J1
Wang, S1
Zhao, X1
Shao, X1
Jiang, X1
Dai, Y1
Xu, S1
Pan, X1
Zubarovskiy, IN1
Mikhailova, MV1
Osipenko, SK1
Zhu, X1
Kim, DW1
Zhao, L2
Willingham, MC2
Cheng, SY2
Ben Slimène, F1
Mhiri, A1
Ben Ali, M1
Slimène, H1
Ben Raies, N1
Karboua, E1
Kim, HJ1
Mok, JO1
Kim, CH1
Kim, YJ1
Kim, SJ1
Park, HK1
Byun, DW1
Suh, K1
Yoo, MH1
Mousa, U1
Yikilmaz, AS1
Nar, A1
Nar Demirer, A1
Ayturk, S1
Tutuncu, NB1
Gursoy, A1
Pak, Y1
Demirag, NG1
Saghir, SA1
Charles, GD1
Bartels, MJ1
Kan, LH1
Dryzga, MD1
Brzak, KA1
Clark, AJ1
Huang, CC1
Hsueh, C1
Liu, FH1
Chao, TC1
Lin, JD1
Ogawa, C1
Kammori, M1
Onose, H1
Yamada, E1
Shimizu, K1
Yamada, T1
Gen, R1
Akbay, E1
Camsari, A1
Ozcan, T1
Vera, P1
Kuhn-Lansoy, C1
Edet-Sanson, A1
Hapdey, S1
Modzelewski, R1
Hitzel, A1
d'Anjou, J1
Basuyau, JP1
Conwell, LS1
Greer, ML1
Stewart, A1
Perry, CF1
Lu, C1
Ying, H1
Yalcin, M1
Bharali, DJ1
Dyskin, E1
Dier, E1
Lansing, L1
Mousa, SS1
Davis, FB1
Davis, PJ1
Mousa, SA1
Taïeb, D1
Sebag, F1
Farman-Ara, B1
Portal, T1
Baumstarck-Barrau, K1
Fortanier, C1
Bourrelly, M1
Mancini, J1
De Micco, C1
Auquier, P1
Conte-Devolx, B1
Henry, JF1
Mundler, O1
Nunes, Vdos S1
Tagliarini, JV1
Marques, ME1
de Godoi, JA1
Mazeto, GM1
Baranauskas, Z1
Valuckas, KP1
Tiskevicius, S1
Mäenpää, HO1
Välimäki, MJ1
Reverter, JL1
Colomé, E1
Kim, KW1
Park, YJ1
Kim, EH1
Park, SY1
Park, DJ2
Ahn, SH1
Jang, HC1
Cho, BY1
Luna, R1
Penín, M1
Seoane, I1
Alvarez, E1
Palmeiro, R1
García-Mayor, R1
Pacini, F3
Castagna, MG1
Kasner, DL1
Spieth, ME1
Starkman, ME1
Zdor-North, D1
Kim, BW1
Daniels, GH1
Harrison, BJ1
Price, A1
Harney, JW1
Larsen, PR1
Weetman, AP1
Baudin, E2
Son, HY1
Nishikawa, A1
Kanki, K1
Okazaki, K1
Kitamura, Y1
Lee, KY1
Umemura, T1
Hirose, M1
Zöphel, K1
Wunderlich, G1
Smith, BR1
Denizot, A1
Delfino, C1
Dutour-Meyer, A1
Fina, F1
Ouafik, L1
Golger, A1
Fridman, TR1
Eski, S1
Witterick, IJ1
Freeman, JL1
Walfish, PG1
Woodrum, DT1
Gauger, PG1
Kuijt, WJ1
Huang, SA1
Pace, L1
Albanese, C1
Salvatore, B1
Storto, G1
Soricelli, A1
Salvatore, M1
Burns-Naas, LA1
Zorbas, M1
Jessen, B1
Evering, W1
Stevens, G1
Ivett, JL1
Ryan, TE1
Cook, JC1
Capen, CC1
Chen, M1
Furman, G1
Theiss, JC1
Webber, S1
Wu, E1
Shetty, B1
Gasser, R1
McClain, RM1
Ogawa, Y1
Sugawara, T1
Seki, H1
Sakuma, T1
Takano, T1
Miyauchi, A2
Ito, Y2
Amino, N2
do Rosário, PW1
Borges, MA1
Alves, MF1
Purisch, S1
Padrão, EL1
Rezende, LL1
Barroso, AL1
Santos, RB1
Melo, TG1
Assumpção, LV1
Tajiri, J1
Takamura, Y1
Miya, A1
Kobayashi, K1
Matsuzuka, F1
Toyoda, N1
Nomura, E1
Nishikawa, M1
David, E1
Rosen, IB1
Bain, J1
James, J1
Kirsh, JC1
Mariotti, S1
Barbesino, G1
Caturegli, P1
Marinò, M1
Manetti, L1
Fugazzola, L1
Pinchera, A1
Francia, G1
Davì, MV1
Petroziello, A1
Sussi, PL1
Staunton, MD1
Schreck, R1
Schnieders, F1
Schmutzler, C1
Köhrle, J1
Samuel, AM1
Mehta, MN1
Desai, KB1
Florkowski, CM1
Brownlie, BE1
Elliot, JR1
Ayling, EM1
Turner, JG1
Betkowski, A1
Gotkowska, K1
Rzepka, M1
Caron, P1
Moreau-Cabarrot, A1
Gorguet, B1
Bazex, J1
Lang, M1
Flesch, M1
Danese, D1
Gardini, A1
Farsetti, A1
Sciacchitano, S1
Andreoli, M1
Pontecorvi, A1
Grobholz, R1
Bittinger, A1
Gerdes, B1
Rothmund, M1
Olveira, G1
Almaraz, MC1
Soriguer, F1
Garriga, MJ1
Gonzalez-Romero, S1
Tinahones, F1
Ruiz de Adana, MS1
Naito, Y1
Sone, T1
Kataoka, K1
Sawada, M1
Yamazaki, K1
Obiols, G1
Simó, R1
Burgos, R1
Tresserras, R1
Galofré, P1
Masmiquel, L1
Hernández, C1
Mesa, J1
Gallowitsch, HJ1
Mikosch, P1
Kresnik, E1
Unterweger, O1
Gomez, I1
Lind, P1
Travagli, JP1
Cailleux, AF1
Ricard, M1
Caillou, B1
Parmentier, C1
Konukoğlu, D1
Hatemi, HH1
Arikan, S1
Demir, M1
Akçay, T1
Cooper, DS1
Specker, B1
Ho, M1
Sperling, M1
Ladenson, PW2
Ross, DS1
Ain, KB1
Bigos, ST1
Brierley, JD1
Haugen, BR1
Klein, I1
Robbins, J1
Sherman, SI1
Taylor, T1
Maxon, HR1
Unal, S1
Menda, Y1
Adalet, I1
Boztepe, H1
Ozbey, N1
Alagöl, F1
Cantez, S1
Garcia-Sanchis, L1
Lopez-Aznar, D2
Oltra, A1
Rivas, A1
Alonso, J1
Montalar, J1
Mateo, A1
Ringel, MD1
Balducci-Silano, PL1
Anderson, JS1
Spencer, CA1
Silverman, J1
Sparling, YH1
Francis, GL1
Burman, KD1
Wartofsky, L1
Levine, MA1
Tuttle, RM1
Schlumberger, MJ2
Schneider, PW1
Meier, DA1
Balon, H1
Mariani, G1
Ferdeghini, M1
Augeri, C1
Villa, G1
Taddei, GZ1
Scopinaro, G1
Boni, G1
Bodei, L1
Rabitti, C1
Molinari, E1
Bianchi, R1
Almeida-Filho, P1
Ravizzini, GC1
Almeida, C1
Borges-Neto, S1
Kondo, T1
Katoh, R1
Omata, K1
Oyama, T1
Yagawa, A1
Kawaoi, A1
Moog, F1
Linke, R1
Manthey, N1
Tiling, R1
Knesewitsch, P1
Tatsch, K1
Hahn, K1
Hrafnkelsson, J1
Tulinius, H1
Kjeld, M1
Sigvaldason, H1
Jónasson, JG1
Torlantano, M1
Haslinghuis, LM1
Krenning, EP2
De Herder, WW1
Reijs, AE1
Kwekkeboom, DJ1
Yunta, PJ1
Ponce, JL1
Prieto, M1
Sancho-Fornos, S1
Lima, N1
Cavaliere, H1
Tomimori, E1
Knobel, M1
Medeiros-Neto, G1
Fatourechi, V1
Hay, ID1
Javedan, H1
Wiseman, GA1
Mullan, BP1
Gorman, CA1
de Geus-Oei, LF1
Oei, HY1
Hennemann, G1
Arici, C1
Erdogan, O1
Altunbas, H1
Boz, A1
Melikoglu, M1
Karayalcin, B1
Karpuzoglu, T1
Ishihara, T1
Ikekubo, K1
Shimodahira, M1
Iwakura, T1
Kobayashi, M1
Hino, M1
Oobayashi, M1
Kohno, K1
Kimura, K1
Kawamura, S1
Kurahachi, H1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Concordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical Samples[NCT06133374]130 participants (Anticipated)Observational2023-12-31Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

16 reviews available for thyroxine and Follicular Thyroid Carcinoma

ArticleYear
Compartment syndrome of the leg after thyroid hormone withdrawal; two cases and a systematic review of the literature.
    BMC endocrine disorders, 2020, Jun-05, Volume: 20, Issue:1

    Topics: Adenocarcinoma, Follicular; Anterior Compartment Syndrome; Compartment Syndromes; Deprescriptions; F

2020
Differentiated Thyroid Cancer-Treatment: State of the Art.
    International journal of molecular sciences, 2017, Jun-17, Volume: 18, Issue:6

    Topics: Adenocarcinoma; Adenocarcinoma, Follicular; Carcinoma, Papillary; Drug Therapy; Enzyme Inhibitors; H

2017
Thyroid-stimulating hormone suppression therapy for differentiated thyroid cancer: The role for a combined T3/T4 approach.
    Head & neck, 2017, Volume: 39, Issue:12

    Topics: Adenocarcinoma, Follicular; Combined Modality Therapy; Drug Therapy, Combination; Evidence-Based Med

2017
Treatment of refractory thyroid cancer.
    Endocrine-related cancer, 2018, Volume: 25, Issue:4

    Topics: Adenocarcinoma, Follicular; Combined Modality Therapy; Humans; Iodine Radioisotopes; Thyroid Neoplas

2018
Skull metastasis from follicular thyroid carcinoma: report of three cases and review of literature.
    International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:11

    Topics: Adenocarcinoma, Follicular; Aged; Biomarkers, Tumor; Biopsy; Cranial Irradiation; Craniotomy; Diseas

2015
Advances in the management of differentiated thyroid cancer with follicular cell strain.
    La Tunisie medicale, 2016, Volume: 94, Issue:3

    Topics: Adenocarcinoma, Follicular; Hormone Replacement Therapy; Humans; Iodine Radioisotopes; Neoplasm Recu

2016
Diagnostic and therapeutic strategies for minimally and widely invasive follicular thyroid carcinomas.
    Surgical oncology, 2011, Volume: 20, Issue:1

    Topics: Adenocarcinoma, Follicular; Adult; Aged; Female; Frozen Sections; Humans; Male; Middle Aged; Retrosp

2011
[Potential risks of the adverse effects of thyrotropin suppression in differentiated thyroid carcinoma].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2011, Volume: 58, Issue:2

    Topics: Adenocarcinoma, Follicular; Aged; Bone Remodeling; Carcinoma, Papillary; Cardiovascular Diseases; Co

2011
Approach to and treatment of differentiated thyroid carcinoma.
    The Medical clinics of North America, 2012, Volume: 96, Issue:2

    Topics: Adenocarcinoma, Follicular; Carcinoma; Carcinoma, Papillary; Cell Differentiation; Combined Modality

2012
Follow-up of differentiated thyroid cancer.
    European journal of nuclear medicine and molecular imaging, 2002, Volume: 29 Suppl 2

    Topics: Adenocarcinoma, Follicular; Autoantibodies; Biomarkers, Tumor; Carcinoma, Papillary; Combined Modali

2002
Follow-up of thyroid cancer patients with favorable prognostic indicators.
    Annales d'endocrinologie, 2003, Volume: 64, Issue:1

    Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; Follow-Up Studies; Humans; Iodine Radioisotopes; N

2003
Role of 131I in the treatment of well differentiated thyroid cancer.
    Journal of surgical oncology, 2005, Mar-01, Volume: 89, Issue:3

    Topics: Adenocarcinoma, Follicular; Antineoplastic Agents, Hormonal; Carcinoma, Papillary; Combined Modality

2005
[Familial nommedullary thyroid cancer].
    Arquivos brasileiros de endocrinologia e metabologia, 2007, Volume: 51, Issue:5

    Topics: Adenocarcinoma, Follicular; Age Factors; Carcinoma, Papillary; Early Diagnosis; Female; Genetic Pred

2007
[Approach to thyroid incidentaloma and follicular adenoma].
    Nihon rinsho. Japanese journal of clinical medicine, 2007, Volume: 65, Issue:11

    Topics: Adenocarcinoma, Follicular; Adenoma; Biopsy, Fine-Needle; Diagnosis, Differential; Diagnostic Imagin

2007
Diagnostic follow-up of well-differentiated thyroid carcinoma: historical perspective and current status.
    Journal of endocrinological investigation, 1999, Volume: 22, Issue:11 Suppl

    Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; Humans; Neoplasm Metastasis; Neoplasm Recurrence,

1999
Papillary and follicular thyroid carcinoma.
    Bailliere's best practice & research. Clinical endocrinology & metabolism, 2000, Volume: 14, Issue:4

    Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; Humans; Iodine Radioisotopes; Neoplasm Metastasis;

2000

Trials

4 trials available for thyroxine and Follicular Thyroid Carcinoma

ArticleYear
Effects of short-term metformin therapy associated with levothyroxine dose decrement on TSH and thyroid hormone levels in patients with thyroid cancer.
    Minerva endocrinologica, 2014, Volume: 39, Issue:1

    Topics: Adenocarcinoma, Follicular; Adult; Body Weight; Carcinoma, Papillary; Dose-Response Relationship, Dr

2014
Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer.
    British journal of clinical pharmacology, 2014, Volume: 78, Issue:5

    Topics: Adenocarcinoma, Follicular; Adult; Carcinoma; Carcinoma, Papillary; Cohort Studies; Dose-Response Re

2014
Iodine biokinetics and radioiodine exposure after recombinant human thyrotropin-assisted remnant ablation in comparison with thyroid hormone withdrawal.
    The Journal of clinical endocrinology and metabolism, 2010, Volume: 95, Issue:7

    Topics: Ablation Techniques; Adenocarcinoma, Follicular; Carcinoma, Papillary; Combined Modality Therapy; Ha

2010
[Should thyroxine treatment be discontinued for four weeks before I(131) thyroid ablation?].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2012, Volume: 59, Issue:4

    Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma, Papillary; Chi-Square Distribution; Drug Adminis

2012

Other Studies

69 other studies available for thyroxine and Follicular Thyroid Carcinoma

ArticleYear
Effects of Chronic Suppression or Oversuppression of Thyroid-Stimulating Hormone on Psychological Symptoms and Sleep Quality in Patients with Differentiated Thyroid Cancer.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2021, Volume: 53, Issue:10

    Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Asymptomatic Diseases; Case-Control Studies; Ch

2021
Radioactive Iodine Therapy in Patients with Differentiated Thyroid Cancer: Study of External Dose Rate Attenuation Law and Individualized Patient Management.
    Thyroid : official journal of the American Thyroid Association, 2019, Volume: 29, Issue:1

    Topics: Adenocarcinoma, Follicular; Adult; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Precisio

2019
Stimulated thyroglobulin level at ablation in differentiated thyroid cancer: the impact of treatment preparation modalities and tumor burden.
    European journal of endocrinology, 2014, Volume: 171, Issue:2

    Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Humans; Iodine Rad

2014
Levothyroxine replacement in hypothyroid humans reduces myocardial lipid load and improves cardiac function.
    The Journal of clinical endocrinology and metabolism, 2014, Volume: 99, Issue:11

    Topics: Adenocarcinoma, Follicular; Adult; Carcinoma, Papillary; Electrocardiography; Female; Heart; Hormone

2014
Recombinant human thyrotropin preparation for adjuvant radioiodine treatment in children and adolescents with differentiated thyroid cancer.
    European journal of endocrinology, 2015, Volume: 173, Issue:6

    Topics: Adenocarcinoma, Follicular; Adolescent; Carcinoma; Carcinoma, Papillary; Child; Humans; Iodine Radio

2015
[LONG-TERM RESULTS OF SURGICAL TREATMENT OF PATIENTS WITH FOLLICULAR TUMORS OF THE THYROID].
    Vestnik khirurgii imeni I. I. Grekova, 2015, Volume: 174, Issue:5

    Topics: Adenocarcinoma, Follicular; Adenoma; Adult; Aged; Diagnosis, Differential; Female; Hormone Replaceme

2015
SAHA-induced loss of tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse model.
    Endocrine-related cancer, 2016, Volume: 23, Issue:7

    Topics: Adenocarcinoma, Follicular; Animals; Carcinogenesis; Disease Models, Animal; Hydroxamic Acids; Mice,

2016
Preoperative serum thyroglobulin and changes in serum thyroglobulin during TSH suppression independently predict follicular thyroid carcinoma in thyroid nodules with a cytological diagnosis of follicular lesion.
    Endocrine research, 2017, Volume: 42, Issue:2

    Topics: Adenocarcinoma, Follicular; Adult; Aged; Biomarkers, Tumor; Female; Humans; Male; Middle Aged; Preop

2017
Stimulated thyroglobulin values above 5.6 ng/ml before radioactive iodine ablation treatment following levothyroxine withdrawal is associated with a 2.38-fold risk of relapse in Tg-ab negative subjects with differentiated thyroid cancer.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2017, Volume: 19, Issue:8

    Topics: Adenocarcinoma, Follicular; Autoantibodies; Carcinoma, Papillary; Catheter Ablation; Female; Follow-

2017
Unresectable huge sternal and mediastinal metastasis of follicular thyroid carcinoma; radiotherapy as first-line and palliative therapy.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2009, Volume: 117, Issue:4

    Topics: Adenocarcinoma, Follicular; Female; Humans; Iodine Radioisotopes; Mediastinal Neoplasms; Middle Aged

2009
Mechanism of trifluralin-induced thyroid tumors in rats.
    Toxicology letters, 2008, Jul-30, Volume: 180, Issue:1

    Topics: Adenocarcinoma, Follicular; Administration, Oral; Animal Feed; Animals; Dose-Response Relationship,

2008
Follicular carcinoma arising from the pyramidal lobe of the thyroid.
    Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2009, Volume: 76, Issue:3

    Topics: Adenocarcinoma, Follicular; Biopsy, Needle; Chemotherapy, Adjuvant; Female; Humans; Thyroid Neoplasm

2009
P-wave dispersion in endogenous and exogenous subclinical hyperthyroidism.
    Journal of endocrinological investigation, 2010, Volume: 33, Issue:2

    Topics: Adenocarcinoma, Follicular; Adenoma; Atrial Fibrillation; Carcinoma, Papillary; Electrocardiography;

2010
Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
    Thyroid : official journal of the American Thyroid Association, 2010, Volume: 20, Issue:1

    Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Child;

2010
Differentiated thyroid carcinoma associated with histological features of Hashimoto's thyroiditis.
    Journal of pediatric endocrinology & metabolism : JPEM, 2009, Volume: 22, Issue:11

    Topics: Adenocarcinoma, Follicular; Adolescent; Female; Hashimoto Disease; Humans; Iodide Peroxidase; Thyroi

2009
Growth activation alone is not sufficient to cause metastatic thyroid cancer in a mouse model of follicular thyroid carcinoma.
    Endocrinology, 2010, Volume: 151, Issue:4

    Topics: Adenocarcinoma, Follicular; Animals; Blotting, Western; Cell Proliferation; Disease Models, Animal;

2010
Tetraiodothyroacetic acid and tetraiodothyroacetic acid nanoparticle effectively inhibit the growth of human follicular thyroid cell carcinoma.
    Thyroid : official journal of the American Thyroid Association, 2010, Volume: 20, Issue:3

    Topics: Adenocarcinoma, Follicular; Analysis of Variance; Animals; Cell Line, Tumor; Cell Proliferation; Cel

2010
A patient with Graves' disease and three types of thyroid carcinoma.
    Thyroid : official journal of the American Thyroid Association, 2010, Volume: 20, Issue:5

    Topics: Adenocarcinoma, Follicular; Aged; Carcinoma; Fatal Outcome; Female; Graves Disease; Humans; Neoplasm

2010
[Outcomes of long-term combined treatment in follicular thyroid carcinoma].
    Medicina (Kaunas, Lithuania), 2010, Volume: 46, Issue:4

    Topics: Adenocarcinoma, Follicular; Adult; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Iod

2010
[Follow-up of papillary and follicular thyroid cancer--when and where?].
    Duodecim; laaketieteellinen aikakauskirja, 2010, Volume: 126, Issue:20

    Topics: Ablation Techniques; Adenocarcinoma, Follicular; Carcinoma, Papillary; Combined Modality Therapy; Di

2010
Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto's thyroiditis.
    Head & neck, 2011, Volume: 33, Issue:5

    Topics: Adenocarcinoma, Follicular; Autoantibodies; Carcinoma, Papillary; Female; Hashimoto Disease; Humans;

2011
Thyroid carcinoma: iodine-131-negative whole-body scan reverses to positive after a combination of thyrogen stimulation and withdrawal.
    Clinical nuclear medicine, 2002, Volume: 27, Issue:11

    Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; False Negative Reactions; Female; Head and Neck Ne

2002
Overexpression of type 2 iodothyronine deiodinase in follicular carcinoma as a cause of low circulating free thyroxine levels.
    The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:2

    Topics: Adenocarcinoma, Follicular; Adult; Aged; Humans; Iodide Peroxidase; Iodothyronine Deiodinase Type II

2003
Synergistic interaction between excess caffeine and deficient iodine on the promotion of thyroid carcinogenesis in rats pretreated with N-bis(2-hydroxypropyl)nitrosamine.
    Cancer science, 2003, Volume: 94, Issue:4

    Topics: Adenocarcinoma, Follicular; Adenoma; Animals; Anti-Infective Agents, Local; Caffeine; Carcinogens; C

2003
Serum thyroglobulin measurements with a high sensitivity enzyme-linked immunosorbent assay: is there a clinical benefit in patients with differentiated thyroid carcinoma?
    Thyroid : official journal of the American Thyroid Association, 2003, Volume: 13, Issue:9

    Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Enzyme

2003
Evaluation of quantitative measurement of thyroglobulin mRNA in the follow-up of differentiated thyroid cancer.
    Thyroid : official journal of the American Thyroid Association, 2003, Volume: 13, Issue:9

    Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma, Papillary; Case-Control Studies; Chemistry, Clin

2003
Three-week thyroxine withdrawal thyroglobulin stimulation screening test to detect low-risk residual/recurrent well-differentiated thyroid carcinoma.
    Journal of endocrinological investigation, 2003, Volume: 26, Issue:10

    Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Carcinoma, Papillary; Cohort Studies; Drug Administra

2003
Children with differentiated thyroid cancer achieve adequate hyperthyrotropinemia within 14 days of levothyroxine withdrawal.
    The Journal of clinical endocrinology and metabolism, 2005, Volume: 90, Issue:11

    Topics: Adenocarcinoma, Follicular; Adolescent; Child; Humans; Iodine Radioisotopes; Retrospective Studies;

2005
Short-term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatment.
    European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:2

    Topics: Adenocarcinoma, Follicular; Adult; Aged; Aged, 80 and over; Disease Progression; Female; Humans; Iod

2006
Increase in thyroid follicular cell tumors in nelfinavir-treated rats observed in a 2-year carcinogenicity study is consistent with a rat-specific mechanism of thyroid neoplasia.
    Human & experimental toxicology, 2005, Volume: 24, Issue:12

    Topics: Adenocarcinoma, Follicular; Administration, Oral; Animals; Aryl Hydrocarbon Hydroxylases; Carcinogen

2005
Thyroid follicular carcinoma metastasized to the lung, skull, and brain 12 years after initial treatment for thyroid gland--case report.
    Neurologia medico-chirurgica, 2006, Volume: 46, Issue:6

    Topics: Adenocarcinoma, Follicular; Aged; Brain Neoplasms; Cerebral Hemorrhage; Combined Modality Therapy; E

2006
Thyroxine to triiodothyronine hyperconversion thyrotoxicosis in patients with large metastases of follicular thyroid carcinoma.
    Thyroid : official journal of the American Thyroid Association, 2006, Volume: 16, Issue:6

    Topics: Adenocarcinoma, Follicular; Adult; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mid

2006
[Follow-up of high-risk patients with differentiated thyroid cancer without persistent disease after initial therapy].
    Arquivos brasileiros de endocrinologia e metabologia, 2006, Volume: 50, Issue:5

    Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; Catheter Ablation; Continuity of Patient Care; Fem

2006
3,5,3'-Triiodothyronine thyrotoxicosis due to increased conversion of administered levothyroxine in patients with massive metastatic follicular thyroid carcinoma.
    The Journal of clinical endocrinology and metabolism, 2008, Volume: 93, Issue:6

    Topics: Adenocarcinoma, Follicular; Adult; Aged; Aged, 80 and over; Disease Progression; Female; Humans; Iod

2008
Management of the hot thyroid nodule.
    American journal of surgery, 1995, Volume: 170, Issue:5

    Topics: Adenocarcinoma; Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; D

1995
Serum soluble interleukin 2 (IL-2) receptor (sIL-2R) in differentiated thyroid carcinoma.
    Journal of endocrinological investigation, 1994, Volume: 17, Issue:11

    Topics: Adenocarcinoma, Follicular; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Papillary; En

1994
[Hormonal therapy in differentiated carcinoma of the thyroid gland].
    Chirurgia italiana, 1994, Volume: 46, Issue:4

    Topics: Adenocarcinoma, Follicular; Adenylyl Cyclases; Biomarkers, Tumor; Carcinoma; Carcinoma, Papillary; H

1994
Thyroid cancer: a multivariate analysis on influence of treatment on long-term survival.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 1994, Volume: 20, Issue:6

    Topics: Adenocarcinoma, Follicular; Adult; Carcinoma; Carcinoma, Papillary; Combined Modality Therapy; Femal

1994
Retinoids stimulate type I iodothyronine 5'-deiodinase activity in human follicular thyroid carcinoma cell lines.
    The Journal of clinical endocrinology and metabolism, 1994, Volume: 79, Issue:3

    Topics: Adenocarcinoma, Follicular; Affinity Labels; Butyrates; Butyric Acid; Cycloheximide; Dactinomycin; H

1994
Thyroid hormones in differentiated thyroid cancer.
    Clinical nuclear medicine, 1994, Volume: 19, Issue:1

    Topics: Adenocarcinoma, Follicular; Bone Neoplasms; Humans; Iodine Radioisotopes; Thyroglobulin; Thyroid Neo

1994
Bone mineral density in patients receiving suppressive doses of thyroxine for thyroid carcinoma.
    The New Zealand medical journal, 1993, Oct-27, Volume: 106, Issue:966

    Topics: Absorptiometry, Photon; Adenocarcinoma, Follicular; Adult; Age Factors; Aged; Bone Density; Carcinom

1993
[Follicular carcinoma of the ectopic lingual thyroid].
    Otolaryngologia polska = The Polish otolaryngology, 1993, Volume: 47, Issue:4

    Topics: Adenocarcinoma, Follicular; Adult; Combined Modality Therapy; Female; Humans; Radiotherapy; Thyroid

1993
Cutaneous metastasis from follicular carcinoma of the thyroid gland.
    Thyroid : official journal of the American Thyroid Association, 1993,Fall, Volume: 3, Issue:3

    Topics: Adenocarcinoma, Follicular; Aged; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Melanoma; R

1993
[T3 hyperthyroidism with metastatic follicular thyroid carcinoma in substitution therapy].
    Nuklearmedizin. Nuclear medicine, 1996, Volume: 35, Issue:5

    Topics: Adenocarcinoma, Follicular; Adult; Female; Humans; Hyperthyroidism; Iodine Radioisotopes; Lymphatic

1996
Thyroid carcinoma in children and adolescents.
    European journal of pediatrics, 1997, Volume: 156, Issue:3

    Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Papillary; Adolescent; Carcinoma, Medullary; Child; Comb

1997
[Development of a thyroid carcinoma after irradiation of the head/neck region].
    Deutsche medizinische Wochenschrift (1946), 1997, Mar-21, Volume: 122, Issue:12

    Topics: Adenocarcinoma, Follicular; Aged; Biopsy, Needle; Female; Goiter, Nodular; Humans; Neoplasms, Radiat

1997
Altered bioavailability due to changes in the formulation of a commercial preparation of levothyroxine in patients with differentiated thyroid carcinoma.
    Clinical endocrinology, 1997, Volume: 46, Issue:6

    Topics: Adenocarcinoma, Follicular; Adult; Aged; Biological Availability; Carcinoma, Papillary; Chemistry, P

1997
Thyroid storm due to functioning metastatic thyroid carcinoma in a burn patient.
    Anesthesiology, 1997, Volume: 87, Issue:2

    Topics: Adenocarcinoma, Follicular; Burns; Humans; Male; Middle Aged; Thyroid Crisis; Thyroid Neoplasms; Thy

1997
[Differentiated thyroid carcinoma, 1972-1992. Follow-up, detection of recurrences and prognostic factors].
    Medicina clinica, 1997, Nov-29, Volume: 109, Issue:19

    Topics: Adenocarcinoma, Follicular; Adult; Carcinoma, Papillary; Combined Modality Therapy; Female; Humans;

1997
Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1998, Volume: 39, Issue:5

    Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; Case-Control Studies; Combined Modality Therapy; F

1998
Combination of radioiodine (131I) and probe-guided surgery for persistent or recurrent thyroid carcinoma.
    The Journal of clinical endocrinology and metabolism, 1998, Volume: 83, Issue:8

    Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; Female; Humans; Iodine Radioisotopes; Lymph Node E

1998
Radioiodine treatment and oxidative stress in thyroidectomised patients for differentiated thyroid cancers.
    Pharmacological research, 1998, Volume: 38, Issue:4

    Topics: Adenocarcinoma, Follicular; Adult; Biomarkers; Carcinoma, Papillary; Erythrocyte Count; Erythrocytes

1998
Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry.
    Thyroid : official journal of the American Thyroid Association, 1998, Volume: 8, Issue:9

    Topics: Adenocarcinoma, Follicular; Adult; Carcinoma, Papillary; Female; Humans; Male; Middle Aged; Prospect

1998
Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1998, Volume: 39, Issue:11

    Topics: Adenocarcinoma, Follicular; Adult; Carcinoma, Papillary; Case-Control Studies; Female; Humans; Iodin

1998
Metastatic follicular thyroid carcinoma to the kidney: a case report.
    Clinical nuclear medicine, 1999, Volume: 24, Issue:1

    Topics: Adenocarcinoma, Follicular; Aged; Female; Humans; Iodine Radioisotopes; Kidney Neoplasms; Lymph Node

1999
Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.
    The Journal of clinical endocrinology and metabolism, 1999, Volume: 84, Issue:11

    Topics: Adenocarcinoma, Follicular; Autoantibodies; Carcinoma, Papillary; Female; Humans; Immunoassay; Iodin

1999
A clear cell variant of follicular carcinoma presenting as an autonomously functioning thyroid nodule.
    Thyroid : official journal of the American Thyroid Association, 2000, Volume: 10, Issue:3

    Topics: Adenocarcinoma, Follicular; Adult; Biopsy, Needle; Diagnosis, Differential; Female; Humans; Iodine R

2000
Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer.
    Cancer biotherapy & radiopharmaceuticals, 2000, Volume: 15, Issue:2

    Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Algorithms; Antineoplastic Agents, Hormonal; Bi

2000
Whole-body Tc-99m sestamibi scintigraphy in the follow-up of differentiated thyroid carcinoma.
    Clinical nuclear medicine, 2000, Volume: 25, Issue:6

    Topics: Adenocarcinoma, Follicular; Adult; Biomarkers, Tumor; Carcinoma; Carcinoma, Papillary; Female; Follo

2000
Incidentally detected liver metastasis of well-differentiated follicular carcinoma of the thyroid, mimicking ectopic thyroid.
    Pathology international, 2000, Volume: 50, Issue:6

    Topics: Adenocarcinoma, Follicular; Cell Differentiation; Choristoma; Diagnosis, Differential; Female; Human

2000
Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2000, Volume: 41, Issue:12

    Topics: Adenocarcinoma, Follicular; Aged; Aged, 80 and over; Carcinoma, Papillary; Female; Fluorodeoxyglucos

2000
Serum thyroglobulin as a risk factor for thyroid carcinoma.
    Acta oncologica (Stockholm, Sweden), 2000, Volume: 39, Issue:8

    Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma, Papillary; Female; Humans; Iceland; Logistic Mod

2000
Somatostatin receptor scintigraphy in the follow-up of patients with differentiated thyroid cancer.
    Journal of endocrinological investigation, 2001, Volume: 24, Issue:6

    Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma, Papillary; Female; Humans; Iodine Radioisotopes;

2001
Solitary adrenal gland metastasis of a follicular thyroid carcinoma presenting with hyperthyroidism.
    Annales d'endocrinologie, 2001, Volume: 62, Issue:3

    Topics: Adenocarcinoma, Follicular; Adrenal Gland Neoplasms; Diagnosis, Differential; Goiter, Nodular; Human

2001
Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.
    Journal of endocrinological investigation, 2002, Volume: 25, Issue:2

    Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary

2002
Lack of impact of radioiodine therapy in tg-positive, diagnostic whole-body scan-negative patients with follicular cell-derived thyroid cancer.
    The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:4

    Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Aged; Carcinoma, Papillary; Female; Gamma Cameras; H

2002
Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
    European journal of nuclear medicine and molecular imaging, 2002, Volume: 29, Issue:6

    Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; False

2002
Differentiated thyroid carcinoma in children and adolescents. Clinical characteristics, treatment and outcome of 15 patients.
    Hormone research, 2002, Volume: 57, Issue:5-6

    Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Adolescent; Adult; Carcinoma, Papillary; Child; Comb

2002
A case of TSH receptor antibody-positive hyperthyroidism with functioning metastases of thyroid carcinoma.
    Endocrine journal, 2002, Volume: 49, Issue:2

    Topics: Adenocarcinoma, Follicular; Aged; Antithyroid Agents; Autoantibodies; Bone Neoplasms; Female; Humans

2002